Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


COPYRIGHT © 2006 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, R. A.
Right arrow Articles by Hill, C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cohen, R. A.
Right arrow Articles by Hill, C.

COPD: Assessing Function


Monday, October 23, 2006

10:30 AM - 12:00 PM

PREVALENCE OF COPD DETECTED IN A COMMUNITY SPIROMETRY SCREENING PROGRAM

Robert A. Cohen, MD, FCCP*, Diana Hackbarth, RN, PhD, Jeanine Solinski, MPP, Rhonda Williams, MES, Christa McKee, Other, Kristen Donnelly, MPH, Lori Younker, Yuanhe Li, MPH and Chalonda Hill, MD

John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

PURPOSE: To determine the prevalence of COPD in a community based spirometry screening program. Chronic Obstructive Pulmonary Disease (COPD) is the 4th leading cause of death in the United States but fewer than half of COPD cases are detected. Early diagnosis using spirometry combined with smoking cessation or removal from exposure can significantly slow the progression of the disease.

METHODS: A year-long public health study of free spirometry testing to assess the prevalence of COPD in Cook and surrounding Illinois counties was implemented. Volunteer respiratory care practitioners were given 4 hours of training on Puritan Bennett Renaissance II spirometers. Subjects were recruited at a national pharmacy chain for a "free lung test" to rule out COPD. A questionnaire eliciting respiratory symptoms, smoking history and exposure history was obtained. Spirometry was performed according to ATS 1994 acceptability and reproducibility criteria and interpreted by pulmonologists. Obstructive defects were categorized according to the GOLD criteria.

RESULTS: 1819 subjects were studied out of which 1265 (70%) had interpretable spirometry. The mean age was 57, 36% were men, 88% were white and half were current or former smokers who had a mean tobacco exposure of 24 pack years. 14% of subjects had significant impairment GOLD COPD category 2 or greater, and 3% had severe or very severe impairment. 60 (67%) of 89 of these impaired subjects in whom complete questionnaire data was available (n=567) were not aware of a previous diagnosis of obstructive lung disease (COPD or asthma). Logistic regression analysis showed that variables which predicted the presence of COPD with impairment were total pack years of tobacco smoke exposure and age (p<.000). BMI had a slight negative predictive value (p<.05).

CONCLUSION: Large scale spirometry screening for COPD can be successfully performed in community settings. A large proportion of subjects with significant impairment were newly diagnosed.

CLINICAL IMPLICATIONS: Mass screening spirometry presents an opportunity to identify early COPD and intervene in disease progression.

DISCLOSURE: Robert Cohen, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.